JP2017214429A5 - - Google Patents

Download PDF

Info

Publication number
JP2017214429A5
JP2017214429A5 JP2017176799A JP2017176799A JP2017214429A5 JP 2017214429 A5 JP2017214429 A5 JP 2017214429A5 JP 2017176799 A JP2017176799 A JP 2017176799A JP 2017176799 A JP2017176799 A JP 2017176799A JP 2017214429 A5 JP2017214429 A5 JP 2017214429A5
Authority
JP
Japan
Prior art keywords
composition
subject
composition according
compound
sweat production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017176799A
Other languages
English (en)
Japanese (ja)
Other versions
JP6461267B2 (ja
JP2017214429A (ja
Filing date
Publication date
Priority claimed from US14/285,488 external-priority patent/US20150259283A1/en
Application filed filed Critical
Publication of JP2017214429A publication Critical patent/JP2017214429A/ja
Publication of JP2017214429A5 publication Critical patent/JP2017214429A5/ja
Application granted granted Critical
Publication of JP6461267B2 publication Critical patent/JP6461267B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017176799A 2014-03-13 2017-09-14 ソフト型抗コリン作動薬類似体についての製剤 Active JP6461267B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201461952505P 2014-03-13 2014-03-13
US61/952,505 2014-03-13
US14/285,488 US20150259283A1 (en) 2014-03-13 2014-05-22 Formulation for soft anticholinergic analogs
US14/285,488 2014-05-22

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016556899A Division JP6293919B2 (ja) 2014-03-13 2015-03-12 ソフト型抗コリン作動薬類似体についての製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018062716A Division JP6756763B2 (ja) 2014-03-13 2018-03-28 ソフト型抗コリン作動薬類似体についての製剤

Publications (3)

Publication Number Publication Date
JP2017214429A JP2017214429A (ja) 2017-12-07
JP2017214429A5 true JP2017214429A5 (enExample) 2018-05-17
JP6461267B2 JP6461267B2 (ja) 2019-01-30

Family

ID=54068191

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2016556899A Active JP6293919B2 (ja) 2014-03-13 2015-03-12 ソフト型抗コリン作動薬類似体についての製剤
JP2017176799A Active JP6461267B2 (ja) 2014-03-13 2017-09-14 ソフト型抗コリン作動薬類似体についての製剤
JP2018062716A Active JP6756763B2 (ja) 2014-03-13 2018-03-28 ソフト型抗コリン作動薬類似体についての製剤
JP2019127508A Active JP6762047B2 (ja) 2014-03-13 2019-07-09 ソフト型抗コリン作動薬類似体についての製剤
JP2020035073A Pending JP2020079321A (ja) 2014-03-13 2020-03-02 ソフト型抗コリン作動薬類似体についての製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016556899A Active JP6293919B2 (ja) 2014-03-13 2015-03-12 ソフト型抗コリン作動薬類似体についての製剤

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018062716A Active JP6756763B2 (ja) 2014-03-13 2018-03-28 ソフト型抗コリン作動薬類似体についての製剤
JP2019127508A Active JP6762047B2 (ja) 2014-03-13 2019-07-09 ソフト型抗コリン作動薬類似体についての製剤
JP2020035073A Pending JP2020079321A (ja) 2014-03-13 2020-03-02 ソフト型抗コリン作動薬類似体についての製剤

Country Status (20)

Country Link
US (8) US20150259283A1 (enExample)
EP (1) EP3116498B1 (enExample)
JP (5) JP6293919B2 (enExample)
KR (3) KR102586868B1 (enExample)
CN (3) CN110917124B (enExample)
AU (2) AU2015229243B2 (enExample)
BR (1) BR112016021011B1 (enExample)
CA (1) CA2941649C (enExample)
DK (2) DK3116498T3 (enExample)
ES (1) ES2710292T3 (enExample)
HU (1) HUE041868T2 (enExample)
IL (1) IL247571B (enExample)
MX (1) MX369129B (enExample)
MY (1) MY183531A (enExample)
PH (1) PH12016501732B1 (enExample)
PL (1) PL3116498T3 (enExample)
PT (2) PT3116498T (enExample)
SG (1) SG11201607480SA (enExample)
WO (1) WO2015138776A1 (enExample)
ZA (1) ZA201607071B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0608249A2 (pt) * 2005-03-03 2009-12-08 Revance Therapeutics Inc formulação, método para aplicação tópica e kit para distribuição transdérmica de toxina botulìnica
AU2014305778B2 (en) 2013-08-08 2019-11-21 Ligand Pharmaceuticals Incorporated Topical compositions and methods of using the same
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
US20180228770A1 (en) * 2015-07-21 2018-08-16 Bodor Laboratories, Inc. Formulation for soft anticholinergic analogs
TWI719046B (zh) 2016-07-21 2021-02-21 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
US11381304B2 (en) * 2017-08-30 2022-07-05 Iridium Satellite Llc Satellite communications with multiple classes of terrestrial terminal devices
TWI838531B (zh) * 2019-05-23 2024-04-11 日商科研製藥股份有限公司 索吡銨溴化物的結晶形態及其製造方法
SG10201912063PA (en) * 2019-12-12 2021-07-29 Nat Skin Centre Singapore Pte Ltd A pharmaceutical formulation
US20230149349A1 (en) 2020-03-03 2023-05-18 Kaken Pharmaceutical Co., Ltd. Medicament containing sofpironium bromide
TW202146010A (zh) 2020-03-03 2021-12-16 日商科研製藥股份有限公司 原發性腋窩多汗症的治療方法及其醫藥
KR102655121B1 (ko) 2021-09-17 2024-04-08 한국식품연구원 락토바실러스 사케이 k040706 균주 검출용 프라이머 세트 및 이의 용도
US11807604B1 (en) * 2022-02-16 2023-11-07 Miralogx Llc Pharmaceutical compounds, pharmaceutical compositions, and methods of treating asthma and other disorders
WO2024026412A1 (en) * 2022-07-28 2024-02-01 Tff Pharmaceuticals, Inc. Thin film freezing methods and compositions formulated from dispersed active agents
KR102611847B1 (ko) * 2023-03-27 2023-12-12 주식회사 이플라스크 무스카린 수용체 길항 활성을 갖는 신규한 피롤리디늄 화합물 및 이의 용도

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK149832C (da) * 1981-07-17 1987-05-18 Riemann Claus Antiperspirantpraeparat bestaaende af to komponenter
DK483587D0 (da) * 1987-09-15 1987-09-15 Riemann & Co Aps Claus Antiperspirant praeparat
US5292530A (en) * 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
CA2014633C (en) * 1989-06-02 2000-07-18 Andrew D. Mccrea Stable anhydrous compositions for topical delivery of active materials
US5232689A (en) * 1990-12-21 1993-08-03 Dow Corning Corporation Translucent antiperspirant compositions
US5143719A (en) 1991-04-16 1992-09-01 Chesebrough-Pond's Usa Co. Anticalculus oral composition containing combinations of organophosphorus polycarboxylate cotelomers and inorganic polyphosphate salts
GB2280111B (en) 1993-07-16 1997-05-07 Union Camp Corp Clear gel antiperpirant compositions
US5895644A (en) * 1997-11-20 1999-04-20 Colgate-Palmolive Company Clear antiperspirant stick with dibenzylidene sorbitol and guar and process of making same
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
US6319491B1 (en) 2000-04-11 2001-11-20 Michael B. Whipple Anti-sweat lotion
EP1438001A4 (en) * 2001-09-26 2006-03-15 Alison B Lukacsko COMPOSITIONS AND METHODS FOR INHIBITING ECCRINS PERSPIRATION IN HUMANS
JP2003113392A (ja) 2001-10-04 2003-04-18 Kiyomitsu Kawasaki 芳香・消臭組成物および該芳香・消臭組成物を含有する人体用芳香・消臭剤
US8252316B2 (en) * 2002-05-03 2012-08-28 Purepharm Inc. Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
BR0308051A (pt) 2003-12-15 2005-09-06 Natura Cosmeticos Sa Composição base para preparação de formulações multifuncionais para o cuidado e proteção da pele e cabelo
US7087560B2 (en) * 2004-10-25 2006-08-08 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Personal care composition with salts of dihydroxypropyltri(C1-C3 alkyl) ammonium monosubstituted polyols
US20060088496A1 (en) * 2004-10-25 2006-04-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions with salts of hydroxypropyl trialkylammonium substituted mono-saccharide
GB0428416D0 (en) * 2004-12-24 2005-02-02 Novartis Ag Organic compounds
GB0428418D0 (en) * 2004-12-24 2005-02-02 Novartis Ag Organic compounds
WO2006069998A2 (de) * 2004-12-27 2006-07-06 Beiersdorf Ag Glycopyrrolat in kosmetischen zubereitungen
WO2007046102A2 (en) * 2005-10-19 2007-04-26 Menni Menashe Zinger Methods for the treatment of hyperhidrosis
CA2627982C (en) 2005-11-10 2013-09-10 Nicholas S. Bodor Soft anticholinergic esters
US7399861B2 (en) * 2005-11-10 2008-07-15 Bodor Nicholas S Soft anticholinergic esters
AU2006201878A1 (en) * 2006-03-13 2007-09-27 Foamix Ltd Foamable composition for hyperhidrosis
JP5371235B2 (ja) * 2006-12-06 2013-12-18 ロート製薬株式会社 皮膚外用剤
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
US8618160B2 (en) 2007-10-18 2013-12-31 Rose U Topical glycopyrrolate formulations
US20100137357A1 (en) * 2008-11-26 2010-06-03 Koleng John J Compositions and methods for hyperhidrosis
US20140037713A1 (en) * 2012-08-03 2014-02-06 Antares Pharma Ipl, Ag Transdermal compositions for anti-cholinergic agents
JP6223543B2 (ja) 2013-03-15 2017-11-01 ボドール ラボラトリーズ, インコーポレイテッド 多汗症の処置のための抗コリン作用性グリコピロレートエステル
WO2015138700A1 (en) 2014-03-13 2015-09-17 Bodor Laboratories, Inc. Use of selected anticholinergic zwitterions
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
US20180228770A1 (en) 2015-07-21 2018-08-16 Bodor Laboratories, Inc. Formulation for soft anticholinergic analogs
TWI719046B (zh) 2016-07-21 2021-02-21 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑

Similar Documents

Publication Publication Date Title
JP2017214429A5 (enExample)
JP2019189650A5 (enExample)
JP2018520198A5 (enExample)
JP2017507970A5 (enExample)
JP5184341B2 (ja) 外用の医薬組成物
JP2016517431A5 (enExample)
CN1307971C (zh) 抗真菌指甲油组合物
MX2025001995A (es) Compuesto heterociclico, procedimiento para prepararlo y uso farmaceutico del mismo
JP2009542657A5 (enExample)
RU2015107877A (ru) Способы лечения болезни альцгеймера и фармацевтические композиции
JP2019517587A5 (enExample)
JP2012520882A5 (enExample)
TWI794222B (zh) 組成物在製備治療睡眠障礙的藥劑的用途
FI3487475T3 (fi) Formulaatio pehmeille antikolinergisille analogeille
JP2013544842A5 (enExample)
JP2016512246A5 (enExample)
RU2012134065A (ru) Альфа-2 адренергический агонист, обладающий эффектом длительного снижения внутриглазного давления
RU2018111436A (ru) Композиция для поддержания доминирования лактобактерий
RU2018130097A (ru) Лечение экземы кистей
RU2018114922A (ru) Лечение очаговой алопеции
JP5922609B2 (ja) 2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性組成物
RU2017134553A (ru) Хорошо растворимые в воде соли фенилалкиламина - быстродействующего блокатора кальциевых каналов, и их применение
TW201622700A (zh) 水性醫藥組成物
US20090281197A1 (en) Acetic Acid/Thymol Compositions and Their Use in the Treatment of Onychomycosis
JP5560588B2 (ja) 眼科用剤